The Food and Drug Administration has officially rescinded the emergency use authorizations (EUAs) for COVID-19 vaccines, a move that ends the legal framework once used to justify broad mandates under the Biden administration.
Secretary of Health and Human Services Robert F. Kennedy Jr. announced the decision on social media, noting that the FDA has now transitioned the vaccines to full marketing authorization for specific age groups and higher-risk populations. Moderna is approved for individuals six months and older, Pfizer for those five and up, and Novavax for ages twelve and above.
Kennedy emphasized that the vaccines remain available for those who want them, particularly vulnerable groups, but without the federal emergency powers that previously compelled widespread compliance. He also highlighted new requirements for placebo-controlled trials to ensure ongoing safety evaluation.
âThe American people demanded science, safety, and common sense,â Kennedy stated, calling the updated framework a fulfillment of his pledge to end mandates, maintain access, and close the emergency phase of pandemic policy.
